Immune Checkpoint Inhibitor-Associated Striatal Encephalitis Presenting with Subacute Progressive Parkinsonism

Mov Disord Clin Pract. 2023 Aug 24;10(Suppl 3):S7-S11. doi: 10.1002/mdc3.13800. eCollection 2023 Aug.

Authors

Tittaya Prasertpan¹, Nattaya Teeyapun², Roongroj Bhidayasiri^{1

3}, Jirada Sringean¹

Affiliations

¹ Chulalongkorn Centre of Excellence for Parkinson's Disease & Related Disorders, Faculty of Medicine Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society Bangkok Thailand.
² Division of Medical Oncology, Department of Medicine, Faculty of Medicine Chulalongkorn University and the King Chulalongkorn Memorial Hospital Bangkok Thailand.
³ The Academy of Science, The Royal Society of Thailand Bangkok Thailand.

PMID: 37636220
PMCID: PMC10448625 (available on 2024-08-24)
DOI: 10.1002/mdc3.13800

No abstract available

Keywords: Atezolizumab; immune checkpoint inhibitor; neurotoxicity; parkinsonism; striatal encephalitis.

Publication types

Case Reports